Pain is a constant in our lives. The efficacy of drug therapy administered by the parenteral route is often limited either by the physicochemical characteristics of the drug itself or by its adsorption-distribution-metabolism-excretion (ADME) mechanisms. One promising alternative is the design of innovative drug delivery systems that can improve the pharmacokinetics |(PK) and/or reduce the toxicity of traditionally used drugs. In this review, we discuss several products that have been approved by the main regulatory agencies (i.e., nano- and microsystems, implants, and oil-based solutions), highlighting the newest technologies that govern both locally and systemically the delivery of drug compounds. Finally, we also highlight the risk assessment of the scale-up process required, given the impact that this approach could have on drug manufacturing. Teaser: The management of pain by way of the parenteral route can be improved using complex drug delivery systems (e.g., micro- and nanosystems) which require high-level assessment and shorten the regulatory pathway.

Repurposing of parentally administered active substances used to treat pain both systemically and locally / Battaglia, Luigi S; Dorati, Rossella; Maestrelli, Francesca; Conti, Bice; Gabriele, Mirko; Di Cesare Mannelli, Lorenzo; Selmin, Francesca; Cosco, Donato. - In: DRUG DISCOVERY TODAY. - ISSN 1359-6446. - ELETTRONICO. - (2022), pp. 0-0. [10.1016/j.drudis.2022.07.006]

Repurposing of parentally administered active substances used to treat pain both systemically and locally

Maestrelli, Francesca
Membro del Collaboration Group
;
Di Cesare Mannelli, Lorenzo
Membro del Collaboration Group
;
2022

Abstract

Pain is a constant in our lives. The efficacy of drug therapy administered by the parenteral route is often limited either by the physicochemical characteristics of the drug itself or by its adsorption-distribution-metabolism-excretion (ADME) mechanisms. One promising alternative is the design of innovative drug delivery systems that can improve the pharmacokinetics |(PK) and/or reduce the toxicity of traditionally used drugs. In this review, we discuss several products that have been approved by the main regulatory agencies (i.e., nano- and microsystems, implants, and oil-based solutions), highlighting the newest technologies that govern both locally and systemically the delivery of drug compounds. Finally, we also highlight the risk assessment of the scale-up process required, given the impact that this approach could have on drug manufacturing. Teaser: The management of pain by way of the parenteral route can be improved using complex drug delivery systems (e.g., micro- and nanosystems) which require high-level assessment and shorten the regulatory pathway.
0
0
Battaglia, Luigi S; Dorati, Rossella; Maestrelli, Francesca; Conti, Bice; Gabriele, Mirko; Di Cesare Mannelli, Lorenzo; Selmin, Francesca; Cosco, Donato
File in questo prodotto:
File Dimensione Formato  
Battaglia et al., 2022.pdf

accesso aperto

Descrizione: paper
Tipologia: Pdf editoriale (Version of record)
Licenza: DRM non definito
Dimensione 1.08 MB
Formato Adobe PDF
1.08 MB Adobe PDF Visualizza/Apri

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2158/1278400
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact